BIRMF (Biorem) Stock Based Compensation: $0.03 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIRMF Biorem Inc BIRMF
87 GF Score
Price $2.23
GF Value $2.07
Valuation Modestly Overvalued
View Full Analysis

What is Biorem Stock Based Compensation?

Biorem BIRMF 87 Stock Based Compensation is $0.03 Mil as of Mar. 2026. GuruFocus rates BIRMF with a GF Score™ of 87/100 and a GF Value™ of $2.07 (Modestly Overvalued).

Biorem's Stock Based Compensation for the three months ended in Mar. 2026 was $0.01 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $0.03 Mil.

Biorem Stock Based Compensation Related Terms

Biorem Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Biorem's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biorem Stock Based Compensation Chart

Biorem Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.07 0.10 0.10 0.05

Biorem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.00 -0.01 0.01
BIRMF
87GF Score
Biorem Inc BIRMF
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biorem Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03 Mil.

What does a Stock Based Compensation of $0.03 Mil mean?
Biorem (BIRMF) has a Stock Based Compensation of $0.03 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Biorem and its competitors.
Is Biorem's Stock Based Compensation too high?
Biorem's current Stock Based Compensation is $0.03 Mil. Overall, Biorem has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biorem's Stock Based Compensation compare to VLTO and ZWS?
Biorem's Stock Based Compensation of $0.03 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for an Industrial Products company?
A good Stock Based Compensation depends on the Industrial Products industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Biorem and its competitors. Biorem's current Stock Based Compensation is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Based on GuruFocus' analysis, Biorem (BIRMF) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.07, compared to a current price of $2.23 — trading 7.7% above its estimated fair value. The current Stock Based Compensation is $0.03 Mil. Biorem's overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Biorem (BIRMF), the current Stock Based Compensation is $0.03 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biorem (BIRMF) Overvalued in 2026?

Based on GuruFocus' analysis, Biorem stock appears to be overvalued. The current stock price of $2.23 is trading 7.7% above its estimated GF Value™ of $2.07. GuruFocus considers Biorem to be Modestly Overvalued.

Key valuation signals for BIRMF:

  • Stock Based Compensation: $0.03 Mil
  • GF Value™: $2.07 vs. price of $2.23 (7.7% above fair value)
  • GF Score™: 87/100

No single metric tells the full story. See the BIRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biorem Business Description

Other Exchanges R6D:GermanyBRM:Canada
Address 7496 Wellington Road 34, RR Number 3, Puslinch, Guelph, ON, CAN, N1H 6H9
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
87GF Score

Get the complete analysis for BIRMF

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.23
Price
$2.07
GF Value